Intellectual Property, Pharmaceuticals And Public Health
Access to Drugs in Developing Countries
Kenneth C. Shadlen
, Samira Guennif
, Alenka Guzmán
, Narayanan Lalitha
Edited by Kenneth C. Shadlen, London School of Economics and Political Science, UK, Samira Guennif, Université Paris 13, France, Alenka Guzmán, Autonomous Metropolitan University-Iztapalapa, Mexico and Narayanan Lalitha, Gujarat Institute of Development Research, India
|2011 352 pp Hardback 978 1 84980 014 3
|2013 Paperback 978 0 85793 879 4
|ebook isbn 978 0 85793 861 9
Hardback £91.00 on-line price £81.90
Paperback £31.00 on-line price £24.80
Available as an eBook for subscribing libraries on .
For individuals at paper price on and
Other eBook partners.
‘This impressive collection offers fascinating new perspectives on the impact of pharmaceutical patents on access to medicines in developing countries. The volume’s editors have put together an important book that sets out clearly the challenges to public health in a wide range of national contexts. The book will be a valuable text for all scholars and decision-makers interested in the global politics of intellectual property rights and public health.’
– Duncan Matthews, Queen Mary, University of London, UK
Contributors: T. Andia, M. Bourassa Forcier, M. Flynn, P. Gehl Sampath, S. Guennif, A. Guzmán, H. Klug, G. Krikorian, N. Lalitha, J.-F. Morin, K.C. Shadlen, L. Shi, M. Watanabe
Full table of contents
This up-to-date book examines pharmaceutical development, access to medicines, and the protection of public health in the context of two fundamental changes that the global political economy has undergone since the 1970s, the globalization of trade and production and the increased harmonization of national regulations on intellectual property rights.
With authors from eleven different countries presenting case studies of national experiences in Africa, Asia and the Americas, the book analyzes national strategies to promote pharmaceutical innovation, while at the same time assuring widespread access to medicines through generic pharmaceutical production and generic pharmaceutical importation. The expert chapters focus on patents as well as an array of regulatory instruments, including pricing and drug registration policies.
Presenting in-depth analysis and original empirical research, this book will strongly appeal to academics and students of intellectual property, international health, international political economy, international development and law.
1. Globalization, Intellectual Property Rights, and Pharmaceuticals: Meeting the Challenges to Addressing Health Gaps in the New International Environment
Kenneth C. Shadlen, Samira Guennif, Alenka Guzmán and N. Lalitha
2. Pharmaceutical Production and Access to Essential Medicines in South Africa
3. Intellectual Property and Access to Medicines: Paradoxes in Moroccan Policy
4. The Invisible Threat: Trade, Intellectual Property, and Pharmaceutical Regulations in Colombia
5. The Challenges of Constructing Pharmaceutical Capabilities and Promoting Access to Medicines in Mexico under TRIPS
6. Corporate Power and State Resistance: Brazil’s Use of TRIPS Flexibilities for its National AIDS Program
7. The Politics of Patents and Drugs in Brazil and Mexico: The Industrial Bases of Health Policies
Kenneth C. Shadlen
8. Pharmaceutical Patent Policy in Developing Countries: Learning from the Canadian Experience
Jean-Frédéric Morin and Mélanie Bourassa Forcier
9. Access to Indian Generic Drugs: Emerging Issues
10. Sufficient but Expensive Drugs: A Double-Track System that Facilitated Supply Capability in China
Mariko Watanabe and Luwen Shi
11. Access to Essential Drugs in Thailand: Intellectual Property Rights and Other Institutional Matters Affecting Public Health in a Developing Country
12. The TRIPS Agreement and Health Innovation in Bangladesh
Padmashree Gehl Sampath